Medivitan Iv Fertigspritze

Cyanocobalamin, the active ingredient in Medivitan Iv Fertigspritze, is a vitamin supplement presented as an injectable solution for intramuscular or intravenous use. It treats vitamin B12, folate and pyridoxine deficiencies and related anemia in patients requiring rapid repletion. GNH USA supplies Medivitan Iv Fertigspritze as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, clinics and pharmacies worldwide.

Medivitan Iv Fertigspritze provides vitamin B‑complex nutrients to correct specific deficiencies and associated hematologic disorders. - Vitamin B12 deficiency: restores normal cobalamin levels and supports red blood cell formation. - Folate deficiency: replenishes folic acid stores, aiding DNA synthesis and hematopoiesis. - Pyridoxine deficiency: corrects vitamin B6 shortage, supporting amino‑acid metabolism and neurotransmitter synthesis. - Anemia due to vitamin deficiency: improves hemoglobin concentration and reduces fatigue.

Adverse reactions may occur following intramuscular or intravenous administration.

Common Side Effects: - Injection site pain - Mild erythema or swelling - Transient headache - Nausea or mild gastrointestinal upset

Serious or Rare Side Effects: - Hypersensitivity reactions including rash, urticaria or anaphylaxis - Severe hypotension or circulatory collapse - Thromboembolic events (very rare) - Methemoglobinemia (extremely rare)

Before using Medivitan Iv Fertigspritze, consider the following safety measures. - Assess vitamin levels: confirm deficiency prior to administration. - Monitor hematologic response: check hemoglobin and blood counts after therapy. - Observe for allergic reactions: watch for rash, itching, or breathing difficulty. - Use caution in renal impairment: adjust monitoring as needed. - Avoid concurrent intravascular injection of incompatible solutions. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Potential drug interactions should be reviewed before initiating therapy.

Major Interactions (Avoid): - High‑dose nitrous oxide: can inactivate vitamin B12 and worsen deficiency. - Intravenous methotrexate: folate antagonism may reduce methotrexate efficacy.

Moderate Interactions (Monitor Closely): - Anticonvulsants (phenytoin, carbamazepine): may increase vitamin B6 requirement. - Oral contraceptives: can affect folate metabolism. - Trimethoprim‑sulfamethoxazole: may impair folate utilization. - High‑dose vitamin C: may increase renal excretion of B‑vitamins.